Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: a multicentre, phase 1/2, open-label, dose-escalation study (Q33394281)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: a multicentre, phase 1/2, open-label, dose-escalation study |
scientific article |
Statements
1 reference
Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: a multicentre, phase 1/2, open-label, dose-escalation study (English)
1 reference
Brianna Harris
1 reference
Paul G Richardson
1 reference
Kenneth C Anderson
1 reference
Nikhil C Munshi
1 reference
Irene M Ghobrial
1 reference
Jacob Laubach
1 reference
Stacey Chuma
1 reference
Scott Rodig
1 reference
Robert Schlossman
1 reference
Janet Kunsman
1 reference
Amy Sam
1 reference
Ravi Vij
1 reference
Ranjit Banwait
1 reference
Andrzej J Jakubowiak
1 reference
Edie Weller
1 reference
Meghan Bagshaw
1 reference
Renee Leduc
1 reference
Philippe Armand
1 reference
Akari Dollard
1 reference
Diane Warren
1 reference
Tiffany Poon
1 reference
21 February 2011
1 reference
1 reference
12
1 reference
263-272
1 reference
Identifiers
1 reference
1 reference